Polygenic Risk Score for Reduced EGFR is Associated with Adverse Events in a Chronic Kidney Disease Cohort — The German Chronic Kidney Disease Study
This clinical trial was presented on day 2 of the th ERA Congress 2022 on May 20 2022 by Drs. Inga Steinbrenner, Zhi Yu, Jin